Company performance
Add to research
Current Price
as of Mar 12, 2025$1.40
P/E Ratio
N/A
Market Cap
$14.99M
- 600036
Description
Add to research
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Metrics
Add to research
Overview
- HQHouston, TX
- SectorHealth Technology
- IndustryBiotechnology
- TickerMRKR
- Price$1.4-3.45%
Trading Information
- Market cap$14.99M
- Float66.75%
- Average Daily Volume (1m)252,430
- Average Daily Volume (3m)142,942
- EPS-$1.08
Company
- Revenue$5.40M
- Rev growth (1yr)647.66%
- Net income-$2.31M
- Gross marginN/A
- EBITDA margin-124.60%
- EBITDA-$2.40M
- EV$16.16M
- EV/Revenue3.00
- P/EN/A
- P/S2.32
- P/B1.67
- Debt/EquityN/A
Documents
Add to research
SEC Filings